Allucent to expedite Covid-19 booster vaccines development

Allucent has received a contract from the BARDA to expedite clinical research and development of next-generation booster vaccines for Covid-19.

Related Keywords

Mark Goldberg ,Human Services ,Clinical Studies Network ,Us Department Of Health ,Administration For Strategic Preparedness ,Strategic Preparedness ,